Copyright
©The Author(s) 2025.
World J Crit Care Med. Sep 9, 2025; 14(3): 105645
Published online Sep 9, 2025. doi: 10.5492/wjccm.v14.i3.105645
Published online Sep 9, 2025. doi: 10.5492/wjccm.v14.i3.105645
Table 2 Studies comparing invasive intracranial pressure monitoring vs no invasive intracranial pressure monitoring from 2020 to 2024
Ref. | Country | Design, sample size | Population | Findings |
Al Saiegh et al[88] | United States | Retrospective cohort, n = 36929 | TBI | ICP monitored patients had a 25% reduction of in-hospital mortality compared to non-ICP monitored patients[79] |
Che et al[89] | China | Retrospective cohort, n = 116 | ICH | No difference in mortality; ICP monitoring predicted of 6-month favorable outcome (OR: 17, 95%CI: 3-95, P = 0.001)[80] |
Ren et al[90] | China | Retrospective cohort, n = 196 | ICH | ICP monitoring group presented higher rate of favorable GOS-E at six-months (OR: 0.54, 95%CI: 0.31-0.93, P = 0.027) |
Li et al[91] | China | Retrospective cohort, n = 91 | Moderate TBI | No difference in 6-month GOS or mortality between the groups |
Robba et al[44] | 42 countries, mostly in Europe | Prospective cohort, n = 2395 | 1287 TBI; 587 ICH; 521 SAH | ICP monitoring group with lower 6-month mortality (34% vs 49%, P < 0.0001) |
Menacho et al[92] | United States | Retrospective cohort, n = 494 | ICH | ICP monitor placement was associated with poor outcome (OR: 2.76, 95%CI: 1.30-5.85, P = 0.008), but not with death (P = 0.652) |
Dallagiacoma et al[93] | 42 countries, mostly in Europe | Prospective cohort, n = 587 | ICH | ICP monitoring is associated with reduction of 6-month mortality (HR: 0.49, 95%CI: 0.35-0.71; P = 0.001) |
Foote et al[94] | United States | Retrospective cohort, n = 123 | Severe TBI | ICP monitored patients had longer length of hospital stay (12 vs 3, P < 0.001) |
Yang et al[47] | China | Prospective cohort, n = 2029 | Severe TBI | ICP monitoring patients had lower in-hospital mortality (19.82% vs 26.83%, P < 0.001) |
Nattino et al[52] | 7 countries in Europe | Prospective cohort, n = 1448 | TBI | Worse 6-month GOS-E for ICP monitored patients (death/vegetative state: 39.2% vs 40.6%; severe disability: 33.2% vs 25.4%; moderate disability: 15.7% vs 14.9%; good recovery: 11.9% vs 19.1%, P = 0.005) |
Shibahashi et al[48] | Japan | Retrospective cohort, n = 31660 | Severe TBI | ICP monitoring associated with lower in-hospital mortality (31,9% vs 39.1%, P < 0.001) and no difference in patients with unfavorable outcomes at discharge (80.3% vs 77.8%, P = 0.127) |
Lee et al[95] | Korea | Retrospective cohort, n = 912 | TBI | No difference in in-hospital mortality (62% vs 58.9%, P = 0.59) or favorable outcome (25.3% vs 24.6%, P = 0.88) |
Waack et al[96] | United States | Retrospective cohort, n = 1664 | TBI | ICP monitoring associated with less mortality (35.1% vs 42.4%, P < 0.01) and discharge home (7.9%, 19.3%, P < 0.001) |
- Citation: Bianchini L, Matos PMPG, Roepke RML, Besen BAMP. Management of intracranial hypertension with and without invasive intracranial pressure monitoring. World J Crit Care Med 2025; 14(3): 105645
- URL: https://www.wjgnet.com/2220-3141/full/v14/i3/105645.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v14.i3.105645